0001104659-21-042505 Sample Contracts

Outlook Therapeutics, Inc. and _____________, As Warrant Agent Form of Common Stock Warrant Agreement Dated As Of __________ Outlook Therapeutics, Inc. Form of Common Stock Warrant Agreement

Warrant Agreement • March 26th, 2021 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Warrant Agreement
• Filed
  March 26th, 2021
• Company
  Outlook Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This Common Stock Warrant Agreement (this “Agreement”), dated as of [●], between Outlook Therapeutics, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

Outlook Therapeutics, Inc. and _____________, As Warrant Agent Form of Preferred Stock Warrant Agreement Dated As Of __________ Outlook Therapeutics, Inc. Form of Preferred Stock Warrant Agreement

Preferred Stock Warrant Agreement • March 26th, 2021 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Preferred Stock Warrant Agreement
• Filed
  March 26th, 2021
• Company
  Outlook Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This Preferred Stock Warrant Agreement (this “Agreement”), dated as of [●], between Outlook Therapeutics, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

Outlook Therapeutics, Inc. and _____________, As Warrant Agent Form of Debt Securities Warrant Agreement Dated As Of __________ Outlook Therapeutics, Inc. Form of Debt Securities Warrant Agreement

Securities Warrant Agreement • March 26th, 2021 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Securities Warrant Agreement
• Filed
  March 26th, 2021
• Company
  Outlook Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This Debt Securities Warrant Agreement (this “Agreement”), dated as of [●], between Outlook Therapeutics, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).